ANI picks up US generics portfolio of Amerigen
ANI acquires the 23 generic products from Amerigen to expand its commercial offering in the US.
Archives for January 13, 2020
Lab urges FDA to suspend ranitidine sales due to degradation risk
Emery Pharma files citizen petition arguing data on the degradation of ranitidine supports suspension of the medicine.
CRO Veristat buys TCTC Group to expand in Europe
Veristat buys The Clinical Trial Company to establish presence in the European contract research sector.
Bristol-Myers offloads manufacturing plant to Catalent
Catalent buys Italian manufacturing and packaging plant from Bristol-Myers Squibb, adding oral solid, biologics and sterile product capacity.
Hikma, Arecor partner on Arestat formulation technology
Hikma taps Arestat, a formulation technology for protein- and peptide-based drugs, to develop an injectable medicine, ahead of filing for US FDA approval.
Bayer, Schrödinger partner on compound developing software project
Bayer to work with Schrödinger on a molecule design software, which will be integrated into the latter’s LiveDesign, a digital drug design platform.